Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00027820

Conditions
Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

NCT01445379

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

NCT02335918

Conditions
Adenocarcinoma, Astrocytoma, Carcinoma, +37 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • The Stanford Center for Clinical and Translational Education and Research Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Medical Center Aurora, Colorado, United States
View all 19 locations
View Trial Details
Completed

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

NCT00106301

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Completed

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

NCT02187042

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • CHU de la Timone Marseille, Cedex 5, France
  • CHU Strasbourg Strasbourg, Cedex, France
  • Centre Hospitalier d'Annecy Annecy, France
  • Centre Catalan Urologie Andrologie Cabestany, France
View all 13 locations
View Trial Details
Completed

Testosterone in Metastatic Renal Cell Carcinoma Patients

NCT03379012

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • A.I. Kryzhanovsky Krasnoyarsk Cancer Center Krasnoyarsk, Russia
  • Kidney Cancer Research Bureau Moscow, Russia
  • RUDN University Moscow, Russia
  • City Clinical Oncology Center Saint Petersburg, Russia
View Trial Details

Related conditions